Abstract
Background
This study aimed to investigate the long-term trends of incident end-stage kidney disease (ESKD) requiring renal replacement therapy (RRT) in Japan using age-period-cohort analysis and evaluated birth cohort effects for incident ESKD requiring RRT.
Methods
The number of incident RRT patients aged between 20 and 84 years by sex from 1982 to 2021 was extracted from the Japanese Society of Dialysis Therapy registry data. Annual incidence rates of RRT were calculated using census population as denominators, and changes in the incidence rates were evaluated using an age-period-cohort model. The age and survey year period categories generated 20 birth cohorts with 5-year intervals (from 1902–1907 to 1997–2001).
Results
The incidence rates of RRT in both sexes initially rose in the birth cohorts born in the early 1900s, and then decelerated and peaked during 1940–1960s in men and 1930–1940s in women, following a steady decline in both sexes. Compared with the reference 1947–1951 birth cohort, the highest cohort rate ratio was 1.14 (95% CI, 1.04–1.25) in the 1967–1971 birth cohort in men and 1.04 (95% CI, 0.98–1.10) in the 1937–1941 birth cohort in women.
Conclusions
Significant cohort effects were identified in both sexes, but the peak of RRT was different for each sex. Our findings suggest that men born between 1940 and 1960s and women born between 1930 and 40 s may be important target populations to consider when decreasing incidence rates of RRT among the general Japanese population.
Similar content being viewed by others
Data availability
The datasets generated and/or analyzed during the current study are available from the corresponding author (MW) on reasonable request.
References
United States Renal Data System (2022) USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD.
Wakasugi M, Kazama JJ, Narita I. Secular trends in end-stage kidney disease requiring renal replacement therapy in Japan: Japanese society of dialysis therapy registry data from 1983 to 2016. Nephrology (Carlton). 2020;25(2):172–8.
Wakasugi M, Narita I. Trends in the incidence of renal replacement therapy by type of primary kidney disease in Japan, 2006–2020. Nephrology (Carlton). 2023;28(2):119–29.
Wakasugi M, Kazama JJ, Narita I. Anticipated increase in the number of patients who require dialysis treatment among the aging population of Japan. Ther Apher Dial. 2014;19(3):201–6.
Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Pub Health. 1991;12:425–57.
Allman-Farinelli MA, Chey T, Bauman AE, Gill T, James WP. Age, period and birth cohort effects on prevalence of overweight and obesity in Australian adults from 1990 to 2000. Eur J Clin Nutr. 2008;62(7):898–907.
Reither EN, Hauser RM, Yang Y. Do birth cohorts matter? Age-period-cohort analyses of the obesity epidemic in the United States. Soc Sci Med. 2009;69(10):1439–48.
Rosenberg PS, Check DP, Anderson WF. A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomark Prev. 2014;23(11):2296–302.
Nakai S, Shinzato T, Sanaka T, Kikuchi K, Kitaoka T, Shinoda T, et al. An overview of dialysis treatment in Japan (as of Dec. 31, 1999). J Jpn Soc Dial Ther. 2001;34(7):1121–47.
Nakai S, Shinzato T, Nagura Y, Masakane I, Kitaoka T, Shinoda T, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2001). Ther Apher Dial. 2004;8(1):3–32.
An overview of regular dialysis treatment in Japan as of 31 December 2003. Ther Apher Dial. 2005;9(6):431–58.
Nakai S, Wada A, Kitaoka T, Shinzato T, Nagura Y, Kikuchi K, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2004). Ther Apher Dial. 2006;10(6):476–97.
Nakai S, Masakane I, Akiba T, Iseki K, Watanabe Y, Itami N, et al. Overview of regular dialysis treatment in Japan (as of 31 December 2005). Ther Apher Dial. 2007;11(6):411–41.
Nakai S, Masakane I, Akiba T, Shigematsu T, Yamagata K, Watanabe Y, et al. Overview of regular dialysis treatment in Japan as of 31 December 2006. Ther Apher Dial. 2008;12(6):428–56.
Nakai S, Masakane I, Shigematsu T, Hamano T, Yamagata K, Watanabe Y, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2007). Ther Apher Dial. 2009;13(6):457–504.
Nakai S, Suzuki K, Masakane I, Wada A, Itami N, Ogata S, et al. Overview of regular dialysis treatment in Japan (as of 31 December 2008). Ther Apher Dial. 2010;14(6):505–40.
Nakai S, Iseki K, Itami N, Ogata S, Kazama JJ, Kimata N, et al. Overview of regular dialysis treatment in Japan (as of 31 December 2009). Ther Apher Dial. 2012;16(1):11–53.
Nakai S, Iseki K, Itami N, Ogata S, Kazama JJ, Kimata N, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2010). Ther Apher Dial. 2012;16(6):483–521.
Nakai S, Hanafusa N, Masakane I, Taniguchi M, Hamano T, Shoji T, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2012). Ther Apher Dial. 2014;18(6):535–602.
Masakane I, Nakai S, Ogata S, Kimata N, Hanafusa N, Hamano T, et al. An overview of regular dialysis treatment in Japan (As of 31 December 2013). Ther Apher Dial. 2015;19(6):540–74.
Masakane I, Nakai S, Ogata S, Kimata N, Hanafusa N, Hamano T, et al. Annual dialysis data report 2014, JSDT renal data registry (JRDR). Renal Rep Ther. 2017;3(1):18.
Masakane I, Taniguchi M, Nakai S, Tsuchida K, Goto S, Wada A, et al. Annual dialysis data report 2015, JSDT renal data registry. Renal Rep Ther. 2018;4(1):19.
Masakane I, Taniguchi M, Nakai S, Tsuchida K, Wada A, Ogata S, et al. Annual dialysis data report 2016, JSDT renal data registry. Renal Rep Ther. 2018;4(1):45.
Nitta K, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, et al. Annual dalysis data report 2017, JSDT renal data registry. Renal Rep Ther. 2019;5(1):53.
Nitta K, Goto S, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, et al. Annual dialysis data report for 2018, JSDT renal data registry: survey methods, facility data, incidence, prevalence, and mortality. Renal Rep Ther. 2020;6(1):41.
Nitta K, Masakane I, Hanafusa N, Hoshino J, Taniguchi M, Joki N, et al. 2019 Annual dialysis data report, JSDT renal data registry. J Jpn Soc Dial Ther. 2020;53(12):579–632 ((in Japanese)).
Hanafusa N, Abe M, Joki N, Hoshino J, Kikuchi K, Goto S, et al. 2020 Annual dialysis data report, JSDT renal data registry. J Jpn Soc Dial Ther. 2021;54(12):611–57 ((in Japanese)).
Hanafusa N, Abe M, Joki N, Hoshino J, Wada A, Kikuchi K, et al. 2021 Annual dialysis data report, JSDT renal data registry. J Jpn Soc Dial Ther. 2022;55(12):665–723 ((in Japanese)).
Wakasugi M, Kazama JJ, Narita I. Use of Japanese society for dialysis therapy dialysis tables to compare the local and national incidence of dialysis. Ther Apher Dial. 2012;16(1):63–7.
Goto Y, Nakayama Y, Yagi T. Influence of the World War II food shortage on the incidence of diabetes mellitus in Japan. Diabetes. 1958;7(2):133–5.
Luyckx VA, Brenner BM. Low birth weight, nephron number, and kidney disease. Kidney Int Suppl. 2005;97:S68-77.
Brenner BM, Charlton J, Luyckx V, Manfellotto D, Perico N, Remuzzi G, Somaschini M, Valensise H, Adu D, Allegaert K, Benedetto C. The impact of kidney development on the life course: a consensus document for action. Nephron. 2017;136(1):3–49.
White SL, Perkovic V, Cass A, Chang CL, Poulter NR, Spector T, et al. Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis. 2009;54(2):248–61.
Lin MY, Chiu YW, Hsu YH, Wu MS, Chang JM, Hsu CC, et al. CKD care programs and incident kidney failure: a study of a national disease management program in Taiwan. Kidney Med. 2022;4(7):100485.
Norio H, Masafumi F. Global dialysis perspective: Japan. Kidney 360. 2020;1(5):416–9.
Yagisawa T, Mieno M, Ichimaru N, Morita K, Nakamura M, Hotta K, et al. Trends of kidney transplantation in Japan in 2018: data from the kidney transplant registry. Renal Rep Ther. 2019;5(1):3.
Acknowledgements
This work was supported by a research grant from JSPS KAKENHI (Grant-in-Aid for Scientific Research, Grant Number JP18K08202) and a grant-in-aid for the contributions to the promotion of measures against chronic kidney disease (CKD) based on the Kidney Disease Control Commission Meeting report, Health, Labour and Welfare Sciences Research Grants (Research on Renal Diseases) from the Ministry of Health, Labour and Welfare, Japan (Grant Number 22FD01001). No funding agencies played any role in the study design, collection, analysis, and interpretation of the data, writing the report, and the decision to submit the report for publication.
We thank the Committee of the Renal Data Registry of the Japanese Society for Dialysis Therapy (JSDT) for permission to use their registry data. The results of the current study were derived from split data from the WADDA system of the JSDT by the authors. However, the interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy or interpretation of the JSDT.
Funding
This work was supported by a research grant from JSPS KAKENHI (Grant-in-Aid for Scientific Research, Grant Number JP18K08202) and a grant-in-aid for the contributions to the promotion of measures against chronic kidney disease (CKD) based on the Kidney Disease Control Commission Meeting report, Health, Labour and Welfare Sciences Research Grants (Research on Renal Diseases) from the Ministry of Health, Labour and Welfare, Japan (Grant Number 22FD01001). No funding agencies played any role in the study design, collection, analysis, and interpretation of the data, writing the report, and the decision to submit the report for publication. The authors declare that they have no other relevant financial interests.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that no conflicts of interest exist.
Research involving Human Participants and/or Animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Obtaining consent was not required because the current analyses used existing national data without any individual patient data.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wakasugi, M., Narita, I. Birth cohort effects in incident renal replacement therapy in Japan, 1982–2021. Clin Exp Nephrol 27, 707–714 (2023). https://doi.org/10.1007/s10157-023-02345-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-023-02345-x